Known targets — ChEMBL curated mechanism
ACVR1ADORA1ADORA2AADORA2BADORA3ESR1ESR2FLT3GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSC1HRH1HTR7IDH1IDH2IRAK1JAK1JAK2JAK3MEN1OPRM1P2RX3PDE5ASCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASIGMAR1SLC6A2SYKTACR1TOP2ATYK2
The experimentally established mechanism targets of Citric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 known ✓ | O00255 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.88 |
| ▸ | HMGCR | P04035 | 1/20 | 0.46 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.46 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.43 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.43 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | ACLY | P53396 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | SLC13A5 | Q86YT5 | 4/20 | 0.41 |
| ▸ | CPT2 | P23786 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Citric Acid SCHEMBL4832768 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL27684023 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL27623018 | 1.00 | ALDH1A1 (0.88) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL26630598 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28117275 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28175509 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28175508 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL28425653 | 0.97 | ALDH1A1 (0.83) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL11857836 | 0.97 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A | |
| Citric Acid SCHEMBL4819877 | 0.97 | ALDH1A1 (0.94) | ALDH1A1HMGCRCHRM1TBXA2RADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 535 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119662625-A | Conjugated microporous polymer-chlorella complex, preparation method thereof and application thereof in treatment of organic pollutants in sewage | 中国科学院生态环境研究中心 | 2025-03-21 | — | — | CN | claimed |
| EP-3192506-B1 | PROPHYLACTIC/AMELIORATING AGENT FOR ADULT DISEASES COMPRISING 5-AMINOLEVULINIC ACID, DERIVATIVE OF 5-AMINOLEVULINIC ACID, OR SALT OF 5-AMINOLEVULINIC ACID OR THE DERIVATIVE OR 5-AMINOLEVULINIC ACID AS ACTIVE INGREDIENT | SBI PHARMACEUTICALS CO LTD (JP) | 2024-12-11 | — | — | EP | claimed |
| EP-4470997-A1 | IRON SUPPLY AGENT FOR PLANT GROWTH | Sobue Clay Co., Ltd. (JP) | 2024-12-04 | — | — | EP | claimed |
| WO-2024214128-A1 | IRON SUPPLY AGENT FOR PLANT GROWTH | ソブエクレー株式会社 | 2024-10-17 | — | — | WO | claimed |
| WO-2024189758-A1 | IRON PREPARATION FOR RAISING ANIMALS/PLANTS AND METHOD FOR PRODUCING SAME, AND IRON SUPPLY AGENT FOR RAISING ANIMALS/PLANTS | ソブエクレー株式会社 | 2024-09-19 | — | — | WO | claimed |
| US-20240173283-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | SBI PHARMACEUTICALS CO., LTD. (JP) | 2024-05-30 | — | — | US | claimed |
| EP-3508200-B1 | AQUEOUS FORMULATION CONTAINING 5-AMINOLEVULINIC ACID OR THE LIKE | SBI PHARMACEUTICALS CO LTD (JP) | 2024-04-10 | — | — | EP | claimed |
| EP-4316480-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | Kyushu University, National University Corporation (JP) | 2024-02-07 | — | — | EP | claimed |
| CN-116997335-A | Preventive or therapeutic agent for side effects of anthracycline anticancer agent | 国立大学法人九州大学 | 2023-11-03 | — | — | CN | claimed |
| WO-2022202477-A1 | PROPHYLACTIC AGENT OR THERAPEUTIC AGENT FOR SIDE EFFECTS OF ANTHRACYCLINE ANTICANCER AGENT | 国立大学法人九州大学 | 2022-09-29 | — | — | WO | claimed |
| WO-2006068697-A2 | COMPOSITIONS INCLUDING IRON | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| WO-2006068729-A2 | METHODS AND COMPOSITIONS FOR ENHANCING IRON ABSORPTION | DRUGTECH CORPORATION (US) | 2006-06-29 | — | — | WO | claimed |
| US-20060134227-A1 | Compositions including iron | DRUGTECH CORPORATION | 2006-06-22 | — | — | US | claimed |
| WO-2003086321-A2 | MODIFIED RELEASE MINERALS | DRUGTECH CORPORATION (US) | 2003-10-23 | — | — | WO | claimed |
| US-20030190355-A1 | Modified release minerals | DRUGTECH CORPORATION | 2003-10-09 | — | — | US | claimed |
| US-5520725-A | Dental glass ionomer cement composition | GC CORPORATION (JP) | 1996-05-28 | — | — | US | claimed |
| EP-0401377-B1 | IRON-CONTAINING PREPARATION FOR USE AS NMR CONTRAST MEDIUM | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1993-09-15 | — | — | EP | claimed |
| US-5174987-A | Administering orally the contrast media consists of sodium carbonate or bicarbonate, ferrous or ferric compounds, and a neutralizing agent; easy to drink; clear and accurate contrast imaging of inner organs | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1992-12-29 | — | — | US | claimed |
| EP-0401377-A1 | IRON-CONTAINING PREPARATION FOR USE AS NMR CONTRAST MEDIUM | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1990-12-12 | — | — | EP | claimed |
| US-4173453-A | Topical hair coloring formulation in the form of suspension, lotion and cream | CDC Research Inc. (US) | 1979-11-06 | — | — | US | claimed |